WORLD
The Aim of the Licence is to Facilitate the Rapid Manufacture and Commercialization of ... - Latest Tweet by World Health Organization
The latest Tweet by World Health Organization states, 'The aim of the licence is to facilitate the rapid manufacture and commercialization of @CSIC’s #COVID19 serological test worldwide. The agreement covers all related patents and the biological material necessary for manufacture of the test. 👉...'
The aim of the licence is to facilitate the rapid manufacture and commercialization of @CSIC’s #COVID19 serological test worldwide. The agreement covers all related patents and the biological material necessary for manufacture of the test.
👉https://t.co/0EwiiWiAw8 pic.twitter.com/7EQI3BnPbt— World Health Organization (WHO) (@WHO) November 23, 2021
(The above story first appeared on LatestLY on Nov 23, 2021 06:32 PM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
